Assembly Biosciences (ASMB) news
Recent news
Assembly Biosciences Q2 basic EPS USD -0.2
AInvest Wire · Aug 13, 2026Assembly Biosciences Q2 operating expenses USD 19.718 million
AInvest Wire · Aug 13, 2026Assembly Biosciences Q2 net income USD -3.857 million
Assembly Biosciences, Inc. (Nasdaq: ASMB) reported a net loss of USD -3.857 million for the second quarter of 2026, reflecting continued investment in its pipeline of antiviral therapeutics. The company’s financial results for the three months ended June 30, 2026, indicate a narrowing of the net…
AInvest Wire · Aug 13, 2026Assembly Biosciences: offering 3.4M common stock at $26.50
Assembly Biosciences, Inc. (Nasdaq: ASMB) recently announced a public offering of 3.4 million shares of common stock at a price of $26.50 per share. The offering is part of the company’s ongoing efforts to raise capital for research, development, and general corporate purposes. The offering is…
AInvest Wire · May 22, 2026Assembly Biosciences announces pricing of $100M offering
Assembly Biosciences, Inc. (Nasdaq: ASMB) has announced the pricing of a $175 million equity offering, which includes the issuance of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, along with accompanying Class A and Class B warrants to…
AInvest Wire · May 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.